Investigating the influence of primary uterine tumor site on pelvic and para-aortic lymph node metastatic pattern and evaluating the risk factors for lymph node metastases in endometrial carcinoma: A retrospective study

被引:3
作者
Zhang, Xiao [1 ,2 ]
Chen, Saihua [3 ]
Li, Guangxiao [1 ,2 ]
Zheng, Limei [1 ,2 ]
Shang, Shanliang [1 ,2 ]
Li, Jianqiong [1 ,2 ]
Guan, Xiaojing [1 ,2 ]
Yang, Jianhua [1 ,2 ]
机构
[1] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Obstet & Gynecol, Hangzhou, Peoples R China
[2] Zhejiang Univ, Sch Med, Key Lab Reprod Dysfunct Management Zhejiang Prov, Hangzhou, Peoples R China
[3] Zhejiang Peoples Hosp, Dept Gynecol, Tiantai Branch, Taizhou, Peoples R China
关键词
endometrial carcinoma; para-aortic lymph node metastasis; pelvic lymph node metastasis; PROGNOSTIC-FACTOR; CANCER; WOMEN; LYMPHADENECTOMY; INVASION; IDENTIFICATION; INTERMEDIATE; SURVIVAL; CORPUS;
D O I
10.1097/MD.0000000000036100
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To assess the metastatic pattern in pelvic and para-aortic lymph nodes in relation with the primary uterine tumor site and to evaluate risk factors for lymph node metastases. 212 patients with endometrial cancer who underwent surgical treatment from December 2014 to December 2019 were selected. The clinical and pathological data were retrospectively analyzed. The factors and uterine primary tumor site related to lymph node metastasis were analyzed by univariate and multivariate analysis. Among the 212 patients with endometrial cancer, 17 cases had lymph node metastasis, and thus the metastasis rate was 8.02%. Univariate analysis revealed that lymph node metastasis was significantly correlated with Federation of Gynecology and Obstetrics stage, depth of myometrial invasion, tumor size, pathological grade, and lymphovascular space invasion (P < .05) and was not correlated with age, pathological type, and cervical involvement (P > .05). Primary uterine tumor site (fundus, horns, body or lower uterine segment) with or without cervical involvement was associated with different lymph nodes' metastatic sites. The lymph node metastatic pathways of endometrial cancer mainly include obturator lymph nodes and para-aortic lymph nodes, and skip metastasis may occur; endometrial carcinoma may jump and metastasize to para-aortic lymph nodes, specially when the lesion is located in the uterine fundus and uterine horns (cornua of uterus); there is a significant correlation between the location of lymph node metastasis and the location of primary uterine malignant tumor.
引用
收藏
页数:7
相关论文
共 51 条
[21]   Evaluating the significance of location of lymph node metastasis and extranodal disease in women with stage IIIC endometrial cancer [J].
Garg, Gunjal ;
Morris, Robert T. ;
Solomon, Leigh ;
Toy, Eugene P. ;
Kruger, Michael ;
Clary, Karen ;
Munkarah, Adnan ;
Wright, Jason D. .
GYNECOLOGIC ONCOLOGY, 2011, 123 (02) :208-213
[22]   Survival benefits of pelvic lymphadenectomy versus pelvic and para-aortic lymphadenectomy in patients with endometrial cancer A meta-analysis [J].
Guo, Weina ;
Cai, Jing ;
Li, Min ;
Wang, Hongbo ;
Shen, Yi .
MEDICINE, 2018, 97 (01)
[23]   Systematic lymphadenectomy in early stage endometrial cancer [J].
Ignatov, Atanas ;
Ivros, Stylianos ;
Bozukova, Mihaela ;
Papathemelis, Thomas ;
Ortmann, Olaf ;
Eggemann, Holm .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2020, 302 (01) :231-239
[24]  
Jobo T, 2005, EUR J GYNAECOL ONCOL, V26, P167
[25]   Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer: Overtreatment Is the Main Issue [J].
Karalok, Alper ;
Turan, Taner ;
Basaran, Derman ;
Turkmen, Osman ;
Kimyon, Gunsu Comert ;
Tulunay, Gokhan ;
Tasci, Tolga .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (04) :748-753
[26]   Comparing risk stratification criteria for predicting lymphatic dissemination in endometrial cancer [J].
Kilts, Toni P. ;
Glaser, Gretchen E. ;
Langstraat, Carrie L. ;
Kumar, Amanika ;
Weaver, Amy L. ;
Mc Gree, Michaela E. ;
Gostout, Bobbie S. ;
Podratz, Karl C. ;
Dowdy, Sean C. ;
Cliby, William A. ;
Mariani, Andrea ;
Bakkum-Gamez, Jamie N. .
GYNECOLOGIC ONCOLOGY, 2019, 155 (01) :21-26
[27]   Efficacy of systematic pelvic endometrial cancer (MRC ASTEC trial): a randomised study [J].
Kitchener, H. ;
Swart, A. M. C. ;
Qian, W. ;
Amos, C. ;
Parmar, M. K. B. .
LANCET, 2009, 373 (9658) :125-136
[28]   Lymph node metastasis in stages I and II ovarian cancer: A review [J].
Kleppe, M. ;
Wang, T. ;
Van Gorp, T. ;
Slangen, B. F. M. ;
Kruse, A. J. ;
Kruitwagen, R. F. P. M. .
GYNECOLOGIC ONCOLOGY, 2011, 123 (03) :610-614
[29]   Uterine Neoplasms, Version 1.2018 Clinical Practice Guidelines in Oncology [J].
Koh, Wui-Jin ;
Abu-Rustum, Nadeem R. ;
Bean, Sarah ;
Bradley, Kristin ;
Campos, Susana M. ;
Cho, Kathleen R. ;
Chon, Hye Sook ;
Chu, Christina ;
Cohn, David ;
Crispens, Marta Ann ;
Damast, Shari ;
Dorigo, Oliver ;
Eifel, Patricia J. ;
Fisher, Christine M. ;
Frederick, Peter ;
Gaffney, David K. ;
George, Suzanne ;
Han, Ernest ;
Higgins, Susan ;
Huh, Warner K. ;
Lurain, John R., III ;
Mariani, Andrea ;
Mutch, David ;
Nagel, Christa ;
Nekhlyudov, Larissa ;
Fader, Amanda Nickles ;
Remmenga, Steven W. ;
Reynolds, R. Kevin ;
Tillmanns, Todd ;
Ueda, Stefanie ;
Wyse, Emily ;
Yashar, Catheryn M. ;
McMillian, Nicole R. ;
Scavone, Jillian L. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (02) :170-199
[30]   Cancer of the corpus uteri: 2021 update [J].
Koskas, Martin ;
Amant, Frederic ;
Mirza, Mansoor Raza ;
Creutzberg, Carien L. .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2021, 155 :45-60